CONSUN PHARMA (01681) proposes a reward program for Caina Technology.

19:39 06/11/2025

Kangqin Pharmaceutical (01681) announced that in order to grant stock rewards to individuals who participate in the growth and development of the group...

CONSUN PHARMA (01681) announced that in order to grant stock rewards to individuals who have contributed to the growth and development of the group, the board of directors proposed the Caina Technology Incentive Plan on November 6, 2025.

LIANLIAN (02598) spent HK$1.631 million on November 6 to repurchase 200,000 shares.

MELCO INT'L DEV (00200): In the third quarter, net revenue attributable to Melco Resorts & Entertainment was 74.7 million US dollars, a year-on-year increase of 174%.

TRADEGO (08017) has announced its interim financial results, with a net profit attributable to shareholders of HK$33.69 million, representing a year-on-year increase of 492.63%.

LIANLIAN (02598) spent HK$1.631 million on November 6 to repurchase 200,000 shares.

MELCO INT'L DEV (00200): In the third quarter, net revenue attributable to Melco Resorts & Entertainment was 74.7 million US dollars, a year-on-year increase of 174%.

TRADEGO (08017) has announced its interim financial results, with a net profit attributable to shareholders of HK$33.69 million, representing a year-on-year increase of 492.63%.